Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adrenocortical Cancer
Studies in the area of adrenocortical cancer reported from C.M. Pacella and co-researchers
June 17th, 2008
In this recently published article, scientists in Rome, Italy conducted a study "To evaluate the feasibility, safety, and clinical benefits of percutaneous laser ablation (PLA) in patients with unresectable primary and metastatic adrenocortical carcinoma (ACC). Four patients with hepatic metastases from ACC and a Cushing's syndrome underwent ultrasound-guided PLA." "In one case the procedure was performed also on the primary tumor. After three sessions of PLA, the primary tumor of 15 cm, was ablated by 75%. After 1-4 (median 1) sessions of PLA, five liver metastases ranging from 2 to 5 cm. were completely ablated, while the sixth tumor of 12 cm was ablated by 75%....
Source: Cancer Weekly (2008-06-17)
|
